Whilst the dynamic range of this assay was low in our hands, making it challenging to apply to higher throughput screening efforts or to concentration responses, it could be adapted by the use of alternative fluorophores with greater signal separation from the nanoluciferase emission peak (Dale et al ., 2019) or using complementation approaches (Inoue et al ., 2019)
Herantis CEO Antti Vuolanto was at TIDES Europe in Hamburg, Germany, to share preliminary results
54 Interestingly, in a similar study of 426,824 individuals, another GIPR variant, Glu288Gly, was associated with lower BMD, but no increase in fracture risk
Your PlexusDx provider can discuss the exact timeline if you're planning to discontinue or switch medications
For example, if you prefer smaller doses, then Ozempic might be a better choice
Keeping a symptom diary can help track changes over time, making it easier to see if semaglutide is effective